Lidochill(tm) Gel
NDC Package 59088-240-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Lidochill(tm) Gel (lidocaine hcl 4%, menthol 1%) gel is ■ Adults and children over 12 years of age: apply a thin layer to the affected area up to 3 to 4 times a day■ Children 12 years of age or younger: consult a doctor. This formulation utilizes a gel delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-240 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
59088-240-16
Package Description
237 mL in 1 BOTTLE, PUMP
Product Code
11-Digit Billing Format
59088024016
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
237 ML
RxNorm Crosswalk
  • RxCUI: 1373137 - lidocaine HCl 4 % / menthol 1 % Topical Gel
  • RxCUI: 1373137 - lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Gel
  • RxCUI: 1373137 - lidocaine hydrochloride 4 % / menthol 1 % Topical Gel

Clinical Specifications

Proprietary Name
Lidochill(tm) Gel
Non-Proprietary Name
Lidocaine Hcl 4%, Menthol 1%
Substance Name
Lidocaine Hydrochloride; Menthol
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
■ Adults and children over 12 years of age: apply a thin layer to the affected area up to 3 to 4 times a day■ Children 12 years of age or younger: consult a doctor

Regulatory & Marketing

Labeler Name
Puretek Corporation
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-08-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59088-240-16 identifies a specific commercial package of 237 ml in 1 bottle, pump of Lidochill(tm) Gel, a human over the counter drug labeled by Puretek Corporation. This product is billed per "ML" milliliter and contains an estimated amount of 237 billable units per package. This gel is formulated for topical use and contains lidocaine hydrochloride; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on September 08, 2025. The current certification is valid through December 31, 2026.

How is this Puretek Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088024016. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 237 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59088-240-16
11-Digit CMS (5-4-2)
59088-0240-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.